You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

O6-BG

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • MGMTP140K-encoding retroviral vector
  • +6 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022

Mesothelioma Trial in Canada, France, Italy (Cisplatin, Pemetrexed, Pembrolizumab)

Active, not recruiting
  • Mesothelioma
  • Calgary, Alberta, Canada
  • +56 more
Nov 8, 2022

Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD) Trial in Worldwide (ampreloxetine, Placebo)

Terminated
Has Results
  • Symptomatic Neurogenic Orthostatic Hypotension
  • +3 more
  • Sun City, Arizona
  • +81 more
Dec 29, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Pathway to Diagnosis of Ovarian Cancer

Active, not recruiting
  • Ovarian Cancer
    • Leuven, Belgium
    • +29 more
    Mar 3, 2021

    Ovarian Cancer Trial in Italy (carboplatin, paclitaxel)

    Active, not recruiting
    • Ovarian Cancer
    • Bari, BA, Italy
    • +27 more
    Mar 2, 2021

    Multiple Sclerosis Trial in Worldwide (Ocrelizumab)

    Recruiting
    • Multiple Sclerosis
    • Buenos Aires, Argentina
    • +161 more
    Aug 2, 2022

    Breast Cancer Trial in Worldwide (Abraxane, Paclitaxel)

    Active, not recruiting
    • Breast Cancer
    • Adelaide, South Australia, Australia
    • +66 more
    Aug 10, 2022

    Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation Trial in China (BG2109, Cetrorelix)

    Not yet recruiting
    • Assisted Reproductive Technology
    • Controlled Ovarian Hyperstimulation
    • Changsha, China
    • +9 more
    Feb 21, 2023

    Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)

    Completed
    • Mesothelioma
    • ADI-PEG 20 plus Pem Cis
    • Placebo plus Pem Cis
    • Phoenix, Arizona
    • +44 more
    Sep 30, 2022

    Crohn's Disease Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Crohn's Disease
    • San Diego, California
    • +134 more
    Mar 13, 2023

    Metastatic Colorectal Cancer Trial in Worldwide (Trifluridine/tipiracil + bevacizumab, Capecitabine + bevacizumab)

    Completed
    Has Results
    • Metastatic Colorectal Cancer
    • Trifluridine/tipiracil + bevacizumab
    • Capecitabine + bevacizumab
    • Camperdown, Australia
    • +56 more
    Oct 3, 2021

    Diarrhea, Cancer Trial in Bratislava (PROBIO-FIX INUM®, Placebo)

    Completed
    • Diarrhea
    • Cancer
    • Probio-Tec® BG-VCap-6.5
    • Placebo
    • Bratislava, Slovakia
      National Cancer Institute
    Dec 12, 2022

    Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Scottsdale, Arizona
    • +197 more
    Jan 2, 2023

    End-Stage Renal Disease, Type 2 Diabetes Trial in Atlanta (Dexcom real-time G6 Continuous Glucose Monitoring System (CGM), POC

    Recruiting
    • End-Stage Renal Disease
    • Type 2 Diabetes
    • Dexcom real-time G6 Continuous Glucose Monitoring System (CGM)
    • POC BG
    • Atlanta, Georgia
    • +1 more
    Feb 18, 2022

    Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

    Completed
    Has Results
    • Glioblastoma
    • Gliosarcoma
    • 3-Dimensional Conformal Radiation Therapy
    • +10 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 4, 2022

    Primary Mitochondrial Myopathy Trial in Worldwide (REN001, Placebo)

    Recruiting
    • Primary Mitochondrial Myopathy
    • La Jolla, California
    • +42 more
    Dec 7, 2022

    Myositis Trial in Worldwide (Nipocalimab, Placebo, Glucocorticoids)

    Recruiting
    • Myositis
    • Scottsdale, Arizona
    • +50 more
    Jan 17, 2023

    Osteoarthritis, Knee Trial in Warszawa, Lódz (SYNOLIS VA 80/160, SYNOLIS VA 40/80)

    Completed
    • Osteoarthritis, Knee
    • SYNOLIS VA 80/160
    • SYNOLIS VA 40/80
    • Warszawa, Poland
    • +2 more
    Apr 13, 2023

    Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

    Recruiting
    • Multiple Sclerosis
    • Cullman, Alabama
    • +202 more
    Jan 27, 2023

    GERD Trial in Ljubljana (Linaprazan Glurate 25 mg, Linaprazan Glurate 50 mg, Linaprazan Glurate 75 mg)

    Recruiting
    • GERD
    • Linaprazan Glurate 25 mg
    • +2 more
    • Ljubljana, Slovenia
      CRS d.o.o,Ukmarjeva ulica 6
    Feb 23, 2023

    Multiple Sclerosis Trial in Worldwide (Mavenclad®)

    Completed
    • Multiple Sclerosis
    • Linz, Austria
    • +91 more
    Dec 16, 2021

    Progressive Multiple Sclerosis (PMS) Trial in Worldwide (Ocrelizumab)

    Active, not recruiting
    • Progressive Multiple Sclerosis (PMS)
    • Laguna Hills, California
    • +125 more
    Jan 13, 2023

    Uterine Fibroids, Heavy Menstrual Bleeding Trial in China (BG2109, Placebo for BG2109, Placebo for add-back therapy)

    Recruiting
    • Uterine Fibroids
    • Heavy Menstrual Bleeding
    • Beijing, China
    • +30 more
    Nov 10, 2022